Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel, Bleomycin, and Platinum in R/M SCCHN
NCT03830385Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2019
- Primary completion
- Feb 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Sun Yat-sen University. Started Feb 2019; status: recruiting.
02
Drugs
nab-paclitaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT03830385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830385.